We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Magic Mushroom Compound Psilocybin Compared to Antidepressant in Breakthrough Trial

News   Apr 14, 2021

 
Psychedelic Compound Compared to Antidepressant in Breakthrough Trial

Ruairi J Mackenzie

Senior Science Writer

@rjmsci

 
 
Advertisement
 

RELATED ARTICLES

Nanoparticles Could Help Get Drugs Through the Blood-Brain Barrier

News

A team of researchers has figured out a way to get through the blood-brain barrier and deliver potent medicine to brain tumors using ultrasound and RNA-loaded nanoparticles.

READ MORE

Damage to White Matter Linked to Worse Post-Brain Injury Outcomes

News

A new study challenges the idea that gray matter is more important than white matter when it comes to cognitive health and function. The findings may help neurologists better predict the long-term effects of strokes and other forms of traumatic brain injury.

READ MORE

Novel Vulnerabilities of Pancreatic Cancer Cells Revealed

News

Researchers have shown that about half of patient-derived pancreatic cancer cell lines are highly dependent or "addicted" to the protein peroxiredoxin 4, as a result of the altered metabolic state of the cancer cell.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE